SuperworthvTv Therapeutics shares outstanding VTVT
Diluted shares outstanding, averaged over each quarter, from 2015.
- Latest quarter, to Jun 30, 2026
- 12.4M
- On a year earlier
- +88.4%
- more shares
vTv Therapeutics had 12.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 88.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 12.4M | +89% |
| FY2024 | 6.6M | +216% |
| FY2023 | 2.1M | +2% |
| FY2022 | 2M | +22% |
| FY2021 | 1.7M | +30% |
| FY2020 | 1.3M | +35% |
| FY2019 | 948.9K | +115% |
| FY2018 | 440.9K | +82% |
| FY2017 | 242.3K | +0% |
| FY2016 | 242.3K | +6% |
| FY2015 | 229.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 12.4M | +88% | |
| Q1 FY26 | 14.6M | +122% | |
| Q4 FY25 | 12.4M | +89% | |
| Q3 FY25 | 8.1M | +48% | |
| Q2 FY25 | 6.6M | +3% | |
| Q1 FY25 | 6.6M | +59% | |
| Q4 FY24 | 6.6M | +216% | |
| Q3 FY24 | 5.5M | +162% | |
| Q2 FY24 | 6.4M | +207% | |
| Q1 FY24 | 4.1M | +99% | |
| Q4 FY23 | 2.1M | +2% | |
| Q3 FY23 | 2.1M | +4% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on vTv Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.